My name is Cindy and I live in Richmond, Vermont. I am working as a data analyst and researcher. I serve as the Chairperson on my union’s benefit advisory committee where I provide input to our HR office on subscriber decisions. As such, I see firsthand what the costs of healthcare and prescription medication can do to a plan, and how these costs impact premiums.

Patients For Affordable Drugs Launches New Website Aimed At Defending Medicare Negotiation

I am Sandra Williams, a 75 year old retiree from Lynchburg, Virginia living with atrial fibrillation (Afib).

I am insured under a Humana Gold Plus Medicare plan and due to my condition, I have to take and adhere to an Eliquis prescription routine. The problem, however, is that even though I am insured, my medical plan considers Eliquis, which has a list price of $594, a tier 4 drug and therefore am expected to pay nearly $500 a month for my monthly supply, after insurance coverage (or lack thereof).

My name is Catherine Benitz and I am from Greeley, Colorado. I am a 70-year-old retired educator who has lived with psoriasis since the age of three in 1956, Sjogren’s syndrome since 2013, and several other immune conditions diagnosed in 2021 and 2022 after getting COVID-19 vaccines.

In 2010, I was diagnosed with Type 2 diabetes and prescribed Jardiance. I am currently on Medicaid and my Medicare health insurance coverage plan is expected to kick in in February. Under Medicaid alone, I would be paying $282 a month just for Jardiance, and still don’t know what that total might be under Medicare. This might not seem like a lot to pay for a necessary medication, but that is a lot for me to pay as someone who is retired and living on a fixed income.

Patients For Affordable Drugs Continues to Fight Against Big Pharma's Attempts to Undermine Medicare Drug Price Negotiation As Some Of The Largest Drug Companies Have Their Day In Court

Patients For Affordable Drugs Responds to Judge's Ruling Against AstraZeneca in The Pharmaceutical Corporation’s Lawsuit Against Medicare Drug Price Negotiation

My name is Jacqueline Garibay and I’m a 22-year-old college student from Austin, Texas. The last time I shared my story I was 19, now three years later some changes have been made but I am still being subjected to Big Pharma’s never-ending greed.